CYDY CytoDyn Inc.
AI brief AI-written, not reviewed by a person
Latest filings show CYDY's cash and equivalents at 16.359 million as of 2026-08-31, up from 11.852 million on 2026-05-31, with stockholders’ equity improving to -98.073 million by 2026-08-31 from -109.718 million on 2026-05-31, while net income for the year turned from -42.699 million to -38.575 million in the 12 months to 2026-05-31 and 2025-05-31 respectively. Operating cash flow worsened year over year, at -17.252 million for the 12 months to 2026-05-31 versus -8.765 million to 2025-05-31. A 12-month revenue figure remains at 0 for 2023 and 0 for 2022, with 2022 revenue previously 266 thousand in the prior period; shares outstanding increased to 1.4695 billion as of 2026-09-30, while total assets rose to 19.054 million and total liabilities to 117.127 million at 2026-08-31.
- Cash and equivalents increased to 16.359 million on 2026-08-31 from 11.852 million on 2026-05-31. [1]
- Diluted EPS (year) for 12 months to 2026-05-31 is -0.03 USD per share, versus 0 USD per share for 12 months to 2025-05-31. [1]
- Stockholders' equity at 2026-08-31 is -98,073,000 USD, compared with -109,718,000 USD at 2026-05-31. [1]
- Net income (year) for the 12 months to 2026-05-31 is -42,699,000 USD, compared with 4,745,000 USD for the 12 months to 2025-05-31. [1]
- Operating cash flow (year) for the 12 months to 2026-05-31 is -17,252,000 USD, versus -8,765,000 USD for the 12 months to 2025-05-31. [1]
- Total assets at 2026-08-31 are 19,054,000 USD; total liabilities at 2026-08-31 are 117,127,000 USD. [1][2]
- Shares outstanding at 2026-09-30 are 1,469,518,000 shares, up from 1,381,942,000 on 2026-06-30. [1]
Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).
What the sources did not support
- No figures presented beyond 2026-08-31 for cash/total assets/liabilities; later periods not provided for some line items.
- Unable to confirm revenue figures beyond 2023-05-31 and 2022-05-31 due to sparse data in sources; 2024-2025 periods not covered.
- Long-term debt entries are historical (2013-2014) and not reconciled with current balance sheet; no current long-term debt figure provided.
- No explicit linkage between quarterly figures and latest annual figures beyond the listed periods.
Observations
| Metric | Value | Observed | Source | Retrieved | Freshness |
|---|---|---|---|---|---|
| Revenue (quarter) (3 months to 2021-11-30) | 225,000 USD | sec-companyfacts | current | ||
| Revenue (year) (12 months to 2023-05-31) | 0 USD | sec-companyfacts | current | ||
| Net income (quarter) (3 months to 2026-08-31) | -19,936,000 USD | sec-companyfacts | current | ||
| Net income (year) (12 months to 2026-05-31) | -42,699,000 USD | sec-companyfacts | current | ||
| Operating income (quarter) (3 months to 2026-08-31) | -6,577,000 USD | sec-companyfacts | current | ||
| Operating income (year) (12 months to 2026-05-31) | -38,575,000 USD | sec-companyfacts | current | ||
| Diluted EPS (quarter) (3 months to 2026-08-31) | -0.01 USD/shares | sec-companyfacts | current | ||
| Diluted EPS (year) (12 months to 2026-05-31) | -0.03 USD/shares | sec-companyfacts | current | ||
| Operating cash flow (quarter) (3 months to 2026-08-31) | -7,726,000 USD | sec-companyfacts | current | ||
| Operating cash flow (year) (12 months to 2026-05-31) | -17,252,000 USD | sec-companyfacts | current | ||
| Total assets (at 2026-08-31) | 19,054,000 USD | sec-companyfacts | current | ||
| Total liabilities (at 2026-08-31) | 117,127,000 USD | sec-companyfacts | current | ||
| Stockholders' equity (at 2026-08-31) | -98,073,000 USD | sec-companyfacts | current | ||
| Cash and equivalents (at 2026-08-31) | 16,359,000 USD | sec-companyfacts | current | ||
| Long-term debt (at 2014-05-31) | 2,338,684 USD | sec-companyfacts | current | ||
| Shares outstanding (at 2026-09-30) | 1,469,518,000 shares | sec-companyfacts | current |
Context
No reviewed context has been published for CYDY. The observations and documents below are shown as their sources stated them.
Documents
Source freshness
| Source | Freshness | Last successful fetch | Stale after | Sources reports |
|---|---|---|---|---|
| SEC EDGAR: company financial facts (XBRL) sec-companyfacts | current | 10080 min | ok | |
| SEC EDGAR: latest XBRL filings sec-xbrl-filings | current | 45 min | healthy |
Watch this instrument
Sign in to add CYDY to a private watchlist or to get an alert when a new document or observation arrives.
Machine-readable: CYDY.json (the same data with every timestamp and source).
Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.